tiprankstipranks
Trending News
More News >
23Andme Holding Co (MEHCQ)
:MEHCQ
US Market

23andMe Holding (MEHCQ) Price & Analysis

Compare
1,322 Followers

MEHCQ Stock Chart & Stats

$3.20
--
Market closed
$3.20
--

23andMe Holding News

MEHCQ FAQ

What was 23Andme Holding Co’s price range in the past 12 months?
Currently, no data Available
What is 23Andme Holding Co’s market cap?
Currently, no data Available
When is 23Andme Holding Co’s upcoming earnings report date?
23Andme Holding Co’s upcoming earnings report date is Feb 11, 2026 which is in 54 days.
    How were 23Andme Holding Co’s earnings last quarter?
    Currently, no data Available
    Is 23Andme Holding Co overvalued?
    According to Wall Street analysts 23Andme Holding Co’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does 23Andme Holding Co pay dividends?
      23Andme Holding Co does not currently pay dividends.
      What is 23Andme Holding Co’s EPS estimate?
      23Andme Holding Co’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does 23Andme Holding Co have?
      Currently, no data Available
      What happened to 23Andme Holding Co’s price movement after its last earnings report?
      Currently, no data Available
      Which hedge fund is a major shareholder of 23Andme Holding Co?
      Currently, no hedge funds are holding shares in MEHCQ
      What is the TipRanks Smart Score and how is it calculated?
      Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

        Company Description

        23Andme Holding Co

        23andMe Holding Co. is a consumer genetics and research company that operates in the healthcare sector. It offers direct-to-consumer genetic testing services, providing customers with insights into their ancestry, genetic health risks, and wellness traits. Through its platforms, the company empowers individuals to access, understand, and benefit from the human genome, thereby promoting personalized healthcare and fostering genetic research.

        23andMe Holding (MEHCQ) Earnings & Revenues

        MEHCQ Revenue Breakdown

        100.00%100.00%0.00%
        100.00% Consumer & Research Services
        0.00% Therapeutics
        tipranks
        Similar Stocks
        Company
        Price & Change
        Follow
        Idexx Laboratories
        Myriad Genetics
        NeoGenomics
        CareDx
        Fulgent Genetics

        Ownership Overview

        6.35%93.65%
        ― Other Institutional Investors
        93.65% Public Companies and
        Individual Investors

        Options Prices

        Currently, No data available
        ---
        Popular Stocks